Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study.
Vignoli CA, Gargiulo L, Ibba L, Balato A, Barbareschi M, Barruscotti S, Bazzacco G, Bellinato F, Bianchi VG, Boccaletti V, Caposiena Caro RD, Ferrucci SM, Fraghì A, Fulgione E, Gallo G, Gisondi P, Giunipero di Corteranzo I, Malagoli P, Marzano AV, Mercuri SR, Orsini D, Quaglino P, Ribero S, Costanzo A, Narcisi A. Vignoli CA, et al. Among authors: gargiulo l. J Dermatolog Treat. 2025 Dec;36(1):2444494. doi: 10.1080/09546634.2024.2444494. Epub 2025 Jan 6. J Dermatolog Treat. 2025. PMID: 39761973 Free article.
Anti-IL-17/23 Drugs for the Treatment of Moderate-to-Severe Hidradenitis Suppurativa in Patients With Concomitant Psoriasis: A Multicenter Retrospective Study.
Gargiulo L, Ibba L, Narcisi A, Giordano S, Maronese CA, Martora F, Repetto F, Paolino G, Balato A, Burlando M, Dapavo P, Dini V, Guarneri C, Marzano AV, Megna M, Mercuri SR, Costanzo A, Valenti M. Gargiulo L, et al. Dermatol Pract Concept. 2024 Oct 30;14(4):e2024250. doi: 10.5826/dpc.1404a250. Dermatol Pract Concept. 2024. PMID: 39652961 Free PMC article.
Long-term effectiveness and safety of risankizumab in patients with moderate-to-severe psoriasis with and without cardiometabolic comorbidities: a single-center retrospective study.
Ibba L, Di Giulio S, Gargiulo L, Facheris P, Perugini C, Costanzo A, Narcisi A, Valenti M. Ibba L, et al. Among authors: gargiulo l. J Dermatolog Treat. 2024 Dec;35(1):2425029. doi: 10.1080/09546634.2024.2425029. Epub 2024 Nov 7. J Dermatolog Treat. 2024. PMID: 39510528 Free article.
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study.
Campione E, Artosi F, Shumak RG, Giunta A, Argenziano G, Assorgi C, Balato A, Bernardini N, Brunasso AMG, Burlando M, Caldarola G, Campanati A, Carugno A, Castelli F, Conti A, Costanzo A, Cuccia A, Dapavo P, Dattola A, De Simone C, Di Lernia V, Dini V, Donini M, Errichetti E, Esposito M, Fargnoli MC, Foti A, Fiorella C, Gargiulo L, Gisondi P, Guarneri C, Legori A, Lembo S, Loconsole F, Malagoli P, Marzano AV, Mercuri SR, Megna M, Micali G, Mortato E, Musumeci ML, Narcisi A, Offidani AM, Orsini D, Paolino G, Pellacani G, Peris K, Potenza C, Prignano F, Quaglino P, Ribero S, Richetta AG, Romanelli M, Rossi A, Strippoli D, Trovato E, Venturini M, Bianchi L. Campione E, et al. Among authors: gargiulo l. Pharmaceuticals (Basel). 2024 Oct 16;17(10):1378. doi: 10.3390/ph17101378. Pharmaceuticals (Basel). 2024. PMID: 39459016 Free PMC article.
Short-term effectiveness and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis: results from a 16-week real-world multicenter retrospective study - il AD (Italian landscape atopic dermatitis).
Gargiulo L, Ibba L, Alfano A, Malagoli P, Amoruso F, Balato A, Barei F, Burroni AG, Caccavale S, Calzavara-Pinton P, Esposito M, Fargnoli MC, Ferrucci SM, Foti C, Girolomoni G, Gola M, Guanti MB, Gurioli C, Magliulo M, Maurelli M, Morrone P, Musumeci ML, Napolitano M, Ortoncelli M, Patruno C, Piraccini BM, Pezzolo E, Ribero S, Rossi M, Savoia P, Sciarrone C, Tirone B, Vaccino M, Veronese F, Costanzo A, Narcisi A. Gargiulo L, et al. J Dermatolog Treat. 2024 Dec;35(1):2411855. doi: 10.1080/09546634.2024.2411855. Epub 2024 Oct 10. J Dermatolog Treat. 2024. PMID: 39389612 Free article.
The Risk of Candidiasis During Treatment with Bimekizumab for the Management of Plaque Psoriasis: A 16-Week Multicenter Real-World Experience - IL PSO (Italian Landscape Psoriasis).
Megna M, Orsini D, Assorgi C, Balato A, Balestri R, Bianchi L, Brianti P, Brunasso G, Buononato D, Burlando M, Cagni AE, Caldarola G, Cameli N, Campanati A, Campione E, Carrera CG, Carugno A, Chersi K, Costanzo A, Cusano F, D'Amico D, Dal Bello G, Dapavo P, Dattola A, De Simone C, Di Lernia V, Dini V, Errichetti E, Esposito M, Fargnoli MC, Fiorella CS, Foti A, Gaiani FM, Gargiulo L, Gatti A, Gisondi P, Giunta A, Ibba L, Lasagni C, Loconsole F, Maione V, Malagoli P, Marzano AV, Maurelli M, Mercuri SR, Michelerio A, Michelucci A, Morrone P, Mortato E, Narcisi A, Offidani A, Paolino G, Parodi A, Pellacani G, Quaglino P, Richetta AG, Romano F, Sena P, Trevisan G, Uzzauto MT, Venturini M, Potestio L. Megna M, et al. Among authors: gargiulo l. Clin Exp Dermatol. 2024 Oct 7:llae400. doi: 10.1093/ced/llae400. Online ahead of print. Clin Exp Dermatol. 2024. PMID: 39373543 No abstract available.
165 results